RefleXion Announces Real-World Evidence Outcomes Registry to Evaluate Treatment Impact on all Stages of Cancer
PREMIER registry to enroll a minimum of 750 patients and include all solid tumor cancers May 03, 2022 10:42 AM Eastern Daylight Time HAYWARD, Calif.–(BUSINESS WIRE)–RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT)* for all stages of cancer, today announced the enrollment of the first…